Oxytocin-Gly-Lys-Arg: A novel cardiomyogenic peptide

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Danalache, Bogdan A ^a   Gutkowska, Jolanta ^a,b   Ślusarz, Magdalena J ^c   Berezowska, Irena ^d   Jankowski, Marek ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF GDA SK   (Poland)

^d CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTININ; ARGININE; GLYCINE; LYSINE; MESSENGER RNA; MYOD PROTEIN; MYOGENIN; OXYTOCIN; OXYTOCIN RECEPTOR; VASOPRESSIN; VASOPRESSIN V1A RECEPTOR; DRUG DERIVATIVE; OXYTOCIN, GLY LYS ARG; OXYTOCIN, GLY-LYS-ARG-; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN; CELL STRAIN P19; CONTROLLED STUDY; EMBRYO; HEART DEVELOPMENT; HEART MUSCLE CELL; HEART VENTRICLE; MOLECULAR DOCKING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; RAT;

RATTUS; RODENTIA;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EMBRYONIC STEM CELLS; IMMUNOHISTOCHEMISTRY; MICE; MODELS, MOLECULAR; OXYTOCIN; RATS; RNA, SMALL INTERFERING;

EID: 78149460647     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013643     Document Type: Article

References (48)

1. Brownstein MJ, Russell JT, Gainer H (1980) Synthesis, transport, and release of posterior pituitary hormones. Science 207: 373-378.
2. Burbach JP, Luckman SM, Murphy D, Gainer H (2001) Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 81: 1197-1267.
3. Morris M, Castro M, Rose JC (1992) Alterations in oxytocin prohormone processing during early development in the fetal sheep. Am J Physiol 263: R738-740.
4. Alstein M, Whitnall MH, House S, Key S, Gainer H (1988) An immunochem-ical analysis of oxytocin and vasopressin prohormone processing in vivo. Peptides 9: 87-105.
5. Altstein M, Gainer H (1988) Differential biosynthesis and posttranslational processing of vasopressin and oxytocin in rat brain during embryonic and postnatal development. J Neurosci 8: 3967-3977.
6. Barberis C, Mouillac B, Durroux T (1998) Structural bases of vasopressin/ oxytocin receptor function. J Endocrinol 156: 223-229.
7. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, et al. (1997) Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A 94: 11704-11709.
8. Jankowski M, Hajjar F, Kawas SA, Mukaddam-Daher S, Hoffman G, et al. (1998) Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci U S A 95: 14558-14563.
9. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, et al. (2004) Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 109: 2872-2877.
10. Jankowski M, Danalache B, Wang D, Bhat P, Hajjar F, et al. (2004) Oxytocin in cardiac ontogeny. Proc Natl Acad Sci U S A 101: 13074-13079.
11. Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J (2002) Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A 99: 9550-9555.
12. Danalache BA, Paquin J, Donghao W, Grygorczyk R, Moore JC, et al. (2007) Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 25: 679-688.
13. Fathi F, Murasawa S, Hasegawa S, Asahara T, Kermani AJ, et al. (2009) Cardiac differentiation of P19CL6 cells by oxytocin. Int J Cardiol 134: 75-81.
14. Hatami L, Valojerdi MR, Mowla SJ (2007) Effects of oxytocin on cardiomyocyte differentiation from mouse embryonic stem cells. Int J Cardiol 117: 80-89.
15. Gassanov N, Devost D, Danalache B, Noiseux N, Jankowski M, et al. (2008) Functional activity of the carboxyl-terminally extended oxytocin precursor Peptide during cardiac differentiation of embryonic stem cells. Stem Cells 26: 45-54.
16. Florian M, Jankowski M, Gutkowska J (2010) Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology 151: 482-491.
17. Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, et al. (2009) Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A 106: 7149-7154.
18. Elabd C, Basillais A, Beaupied H, Breuil V, Wagner N, et al. (2008) Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis. Stem Cells 26: 2399-2407.
19. Gimpl G, Reitz J, Brauer S, Trossen C (2008) Oxytocin receptors: ligand binding, signalling and cholesterol dependence. Prog Brain Res 170: 193-204.
20. Gassanov N, Jankowski M, Danalache B, Wang D, Grygorczyk R, et al. (2007) Arginine vasopressin-mediated cardiac differentiation: insights into the role of its receptors and nitric oxide signaling. J Biol Chem 282: 11255-11265.
21. Bloch W, Fleischmann BK, Lorke DE, Andressen C, Hops B, et al. (1999) Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43: 675-684.
22. Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, et al. (2004) Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci U S A 101: 12277-12281.
23. Viero C, Shibuya I, Kitamura N, Verkhratsky A, Fujihara H, et al. (2010) Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy. CNS Neurosci Ther.
24. Dudzinski DM, Igarashi J, Greif D, Michel T (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 46: 235-276.
25. Cattaneo MG, Chini B, Vicentini LM (2008) Oxytocin stimulates migration and invasion in human endothelial cells. Br J Pharmacol 153: 728-736.
26. Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, et al. (2009) Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J Cardiovasc Pharmacol 54: 510-519.
27. Mora-Castilla S, Tejedo JR, Hmadcha A, Cahuana GM, Martin F, et al. (2010) Nitric oxide repression of Nanog promotes mouse embryonic stem cell differentiation. Cell Death Differ 17: 1025-1033.
28. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, et al. (1999) Human vascular endothelial cells express oxytocin receptors. Endocrinology 140: 1301-1309.
29. Yamamoto K, Ikeda U, Okada K, Saito T, Kawahara Y, et al. (1997) Arginine vasopressin increases nitric oxide synthesis in cytokine-stimulated rat cardiac myocytes. Hypertension 30: 1112-1120.
30. Nakamura Y, Haneda T, Osaki J, Miyata S, Kikuchi K (2000) Hypertrophic growth of cultured neonatal rat heart cells mediated by vasopressin V(1A) receptor. Eur J Pharmacol 391: 39-48.
31. Abdelalim EM, Tooyama I (2009) BNP signaling is crucial for embryonic stem cell proliferation. PLoS One 4: e5341.
32. Mujoo K, Sharin VG, Bryan NS, Krumenacker JS, Sloan C, et al. (2008) Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci U S A 105: 18924-18929.
33. Wobus AM, Boheler KR (2005) Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85: 635-678.
34. Skerjanc IS (1999) Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc Med 9: 139-143.
35. Skerjanc IS, McBurney MW (1994) The E box is essential for activity of the cardiac actin promoter in skeletal but not in cardiac muscle. Dev Biol 163: 125-132.
36. Postina R, Kojro E, Fahrenholz F (1996) Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem 271: 31593-31601.
37. Fanelli F, Barbier P, Zanchetta D, de Benedetti PG, Chini B (1999) Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol Pharmacol 56: 214-225.
38. Slusarz MJ, Slusarz R, Ciarkowski J (2006) Molecular dynamics simulation of human neurohypophyseal hormone receptors complexed with oxytocin-modeling of an activated state. J Pept Sci 12: 171-179.
39. Holmes CL, Landry DW, Granton JT (2003) Science review: Vasopressin and the cardiovascular system part 1-receptor physiology. Crit Care 7: 427-434.
40. Moore JC, Spijker R, Martens AC, de Boer T, Rook MB, et al. (2004) A P19Cl6 GFP reporter line to quantify cardiomyocyte differentiation of stem cells. Int J Dev Biol 48: 47-55.
41. Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, et al. (2005) Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res 126: 73-81.
42. Szeto A, Nation DA, Mendez AJ, Dominguez-Bendala J, Brooks LG, et al. (2008) Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab 295: E1495-1501.
43. Jankowski M, Bissonauth V, Gao L, Gangal M, Wang D, et al. (2010) Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol 105: 205-218.
44. Ondrejcakova M, Ravingerova T, Bakos J, Pancza D, Jezova D (2009) Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion. Can J Physiol Pharmacol 87: 137-142.
45. Mitchell BF, Fang X, Wong S (1998) Role of carboxy-extended forms of oxytocin in the rat uterus in the process of parturition. Biol Reprod 59: 1321-1327.
46. Loichot C, Krieger JP, De Jong W, Nisato D, Imbs JL, et al. (2001) High concentrations of oxytocin cause vasoconstriction by activating vasopressin V1A receptors in the isolated perfused rat kidney. Naunyn Schmiedebergs Arch Pharmacol 363: 369-375.
47. Favaretto AL, Ballejo GO, Albuquerque-Araujo WI, Gutkowska J, Antunes-Rodrigues J, et al. (1997) Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides 18: 1377-1381.
48. Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49: 3315-3321.